1-(2-Methoxyphenyl)piperazine

HCID 1346CAS 35386-24-4

Basic information

Standard SMILES
COc1ccccc1N1CCNCC1
InChIKey
VNZLQLYBRIOLFZ-UHFFFAOYSA-N
Molecular formula
C11H16N2O
Average molar mass
192.26 g/mol
Monoisotopic mass
192.12626313

Overview

1-(2-methoxyphenyl)piperazine is a member of piperazines.

Names & identifiers

Preferred name
1-(2-Methoxyphenyl)piperazine
IUPAC
1-(2-methoxyphenyl)piperazine
English name
1-(2-Methoxyphenyl)piperazine
Molecular formula
C11H16N2O
Molecular weight
192.26

Names & synonyms

1-(2-Methoxyphenyl)piperazine35386-24-4N-(2-methoxyphenyl)piperazine81NJO1330Ao-methoxyphenylpiperazineDTXSID40188871D-15157RefChem:4224241-(ortho-methoxyphenyl)piperazineDTXCID00111362252-537-71-(2-Methoxyphenyl)-piperazine
Show more names
D 15157AKOS BBS-00003584Uradil impurity 18Urapidil Impurity 6TIMTEC-BB SBB003620RARECHEM AH CK 01262-PiperazinoanisoleUrapidil Impurity CLABOTEST-BB LT00233095
2-MPP1-(o-Methoxyphenyl)piperazinePiperazine, 1-(2-methoxyphenyl)-1-(2-Methoxy-phenyl)-piperazineMFCD000059582-methoxyphenylpiperazine1-(2-methoxy phenyl) piperazine1-(o-Anisyl)piperazine

Database identifiers

CAS
35386-24-4
PubChem CID
1346
DTXSID
DTXSID40188871
ChEMBL
CHEMBL9666
ChEBI
CHEBI:104020
UNII
81NJO1330A
EC Number
252-537-7
Nikkaji
J149.916E

Properties

Computed structural properties

XLogP
1.4
Topological polar surface area
24.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
2
Heavy atoms
14

Experimental & physicochemical properties

DrugsDEA NFLIS-Drug Category -> Piperazines (Stimulant)
LogP1.09
Collision Cross Section140.5 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
35 · 35-40 °C (lit.)
Boiling point
130 · 130-133 °C/0.1 mmHg (lit.)
Density
1.095 g/mL · 1.095 g/mL at 25 °C (lit.)
refractive index
20 · n20/D 1.575(lit.)
Flash point
230 °F · >230 °F
storage temp.
Keep in dark place,Inert atmosphere,Room temperature

Safety & regulation

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 12.3% (7 of 57) of reports.

Danger

H314 (84.2%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]

P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 57 reports by companies from 9 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory InformationStatus: Active Update: 19-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/20083
Hazard Classes and CategoriesSkin Corr. 1B (84.2%)

Safety data

F
3-10
PPE
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
3
ridadr
UN 3263 8/PG 3
hs_code
29349990
risk_code
34-36/37/38

Chemistry & industry

Applications · 3 items

UsesA piperazine derivative and a selective antagonist at D3 receptors that influences the expression of cocaine-induced conditioned place preference (CPP).

UsesIt is used as pharmaceutical intermediate. N-alkylated 1-(2-methyoxyphenyl)piperazines markedly improved affinity and selectivity of the dopamine D3 receptor which is recognized as a potential therapeutic target for the treatment of various neurological and psychiatric disorders.

Uses1-(2-Methoxyphenyl)piperazine can be used:To functionalize pyrazolylvinyl ketones via Aza-Michael addition reaction.To prepare cyclic amine substituted Trger′s base derivatives.To prepare functionalized bis(mercaptoimidazolyl)borates by reacting with the activated ester, [(1-methyl-2-mercaptoimidazol-5-yl)carbonyl]succinimide.

Suppliers50 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
济南百隆化学有限公司[email protected] · [email protected]
HubeiwidelychemicaltechnologyCo.,Ltd18627774460 · [email protected]

Additional notes

DefinitionChEBI: 1-(2-methoxyphenyl)piperazine is a member of piperazines.

Related reactions

586 records

Linked notes

Loading…